No abstract available.
Esophageal Neoplasms*

No abstract available.
Esophageal Neoplasms*

No abstract available.
Esophageal Neoplasms*

No abstract available.
Esophageal Neoplasms*

No abstract available.
Esophageal Neoplasms

No abstract available.
Esophageal Neoplasms*

Background: Lewis surgery has been applied in the Department of Digestive Surgery, Viet-Duc hospital since 1991 and became routine surgery in the treatment of the lower two-thirds of the esophagus cancer. Objective: To present Lewis technique and results of operation in treating the lower two-thirds of the esophagus cancer. Subjects and methods: The study was carried out on 90 patients (86 men and 4 women) with the lower two-thirds of the esophagus cancer operated by the Lewis\u2019s technique. The average age of these patients was 52.3 \xb1 9.2. \r\n', u'Results: Disease stages: stage I: 2 cases (2.2%), stage IIA: 23 cases (25.6%), stage IIA: 23 cases (25.6%), stage IIB: 10 cases (11.1%), stage III: 42 cases (46.7%), stage IV: 13 cases (14.4%). There were three cases of postoperative death (5.6%). 34 cases had surgical complications or complications after surgery. The average survival time of patients after surgery was 23.8 months \xb1 2.8. Postoperative survival time of 1 year, 2 years, 3 years, 5 years was 58.2%, 39.2%, 23.4% and 12.0% respectively.\r\n', u'Conclusion: Mortality and postoperative complications of the surgery were low. So it should be selected for the treatment of the lower two-thirds of the esophagus cancer. The surgery helped 96.5% of patients to eat normally again. 5-year survival time after surgery was low because of diagnosis and surgery in late stages\r\n', u'\r\n', u'
Esophageal Neoplasms/ surgery

Background: Surgical treatment of esophageal carcinoma is a main operation in term of both technique and anesthesiology. The Orringer technique is one of the treatments. Objectives: 1. To describe clinical and subclinical characteristics of the middle and lower-third esophageal carcinoma. 2. To assess preliminary results of Orringer technique in treating of the middle and lower-third esophageal carcinoma. Subjects and method: A prospective, descriptive, following by time study was conducted in the patients who were diagnosed the middle and lower third esophageal carcinoma and operated by Orringer technique at the Department of Digestive Surgery in Viet Duc Hospital from January/2000 to June/2006. Results: The subclinical symptoms included difficult swallow (98.5%), anorexia and loss weight (98.5%), pain in chest (23.5%), loss of voice (2.9%) and bloody vomiting (5.9%). For clinical symptoms, 54/68 patients (79.4%) had lesions in lower-third esophageal, 14/68 (20.6%) had lesions in the middle-third esophageal. The average length of the lesions was 6.23\xb12.22cm (95% CI=5.69-6.77). The average operation time was 273.38 \xb154.56 minutes (range: 140-420), which is much faster than those in esophagectomy via thoracotomy: Lewis-Santy technique (324 minutes) and Akiyama technique (480 minutes). Both intraoperative and post-operative complications of Orringer technique were less than those of esophagectomy via thoracotomy. Conclusion: In this study, the clinical and subclinical strongest characteristics of the patients with the middle-third esophageal carcinoma appear in the advanced period (III period and IV period (over 70%)). Orringer technique had faster operation time, less complications and lower mortality than those of esophagectomy via thoracotomy.
Esophageal Neoplasms/ surgery ; therapy

Review of 84 patients with esophagus cancer operated from 1994 to 2000 by different techniques of esophagectomy was presented. 77 patients alived after operation were followed up to for survival and 12 prognosis factors were referred to this study. Survival time was calculated as 57.3%, 2 years survival 34.3%, 3 years survival 24.2%, and 5 years survival was 10.2%. By single analysis method, 5 factors having affected significantly to survival time were palliative or curative operation, the degree of differentiation of the tumour, ganglion metastasis and the TNM staging (p<0.05).
Surgery ; Esophageal Neoplasms

No abstract available.
Esophageal Neoplasms* ; Esophagus* ; Radiotherapy*